BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamel HFM, Al-Amodi HSAB. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine. Genomics Proteomics Bioinformatics 2017;15:220-35. [PMID: 28813639 DOI: 10.1016/j.gpb.2016.11.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Olbryt M. Potential Biomarkers of Skin Melanoma Resistance to Targeted Therapy—Present State and Perspectives. Cancers 2022;14:2315. [DOI: 10.3390/cancers14092315] [Reference Citation Analysis]
2 Shimura T, Tada Y, Hirai H, Kawakita D, Kano S, Tsukahara K, Shimizu A, Takase S, Imanishi Y, Ozawa H, Okami K, Sato Y, Sato Y, Fushimi C, Takahashi H, Okada T, Sato H, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Ando M, Kohsaka S, Hanazawa T, Chazono H, Kadokura Y, Kobayashi H, Nagao T. Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas. Oncotarget 2018;9:1852-67. [PMID: 29416736 DOI: 10.18632/oncotarget.22927] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
3 Corton JC, Kleinstreuer NC, Judson RS. Identification of potential endocrine disrupting chemicals using gene expression biomarkers. Toxicology and Applied Pharmacology 2019;380:114683. [DOI: 10.1016/j.taap.2019.114683] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
4 Kaur H, Dhall A, Kumar R, Raghava GPS. Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data. Front Genet 2019;10:1306. [PMID: 31998366 DOI: 10.3389/fgene.2019.01306] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
5 Pinker K, Chin J, Melsaether AN, Morris EA, Moy L. Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment. Radiology 2018;287:732-47. [PMID: 29782246 DOI: 10.1148/radiol.2018172171] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 20.8] [Reference Citation Analysis]
6 Guerenne-Del Ben T, Couderc V, Duponchel L, Sol V, Leproux P, Petit JM. Multiplex coherent anti-Stokes Raman scattering microspectroscopy detection of lipid droplets in cancer cells expressing TrkB. Sci Rep 2020;10:16749. [PMID: 33028922 DOI: 10.1038/s41598-020-74021-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Xu X, Hu J, Lyu X, Huang H, Cheng X. Exploring the Interdisciplinary Nature of Precision Medicine:Network Analysis and Visualization. JMIR Med Inform 2021;9:e23562. [PMID: 33427681 DOI: 10.2196/23562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mahmoudian RA, Gharaie ML, Abbaszadegan MR, Alasti A, Forghanifard MM, Mansouri A, Gholamin M. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma. Mol Cell Biochem 2021;476:2465-78. [PMID: 33604811 DOI: 10.1007/s11010-021-04089-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chang HR, Jung E, Cho S, Jeon YJ, Kim Y. Targeting Non-Oncogene Addiction for Cancer Therapy. Biomolecules 2021;11:129. [PMID: 33498235 DOI: 10.3390/biom11020129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li R, Ting YH, Youssef SH, Song Y, Garg S. Three-Dimensional Printing for Cancer Applications: Research Landscape and Technologies. Pharmaceuticals (Basel) 2021;14:787. [PMID: 34451884 DOI: 10.3390/ph14080787] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gravett AM, Dennis JL, Dalgleish AG, Copier J, Liu WM. The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents. Oncol Lett 2020;20:321. [PMID: 33093925 DOI: 10.3892/ol.2020.12184] [Reference Citation Analysis]
12 Rahman MR, Islam T, Gov E, Turanli B, Gulfidan G, Shahjaman M, Banu NA, Mollah MNH, Arga KY, Moni MA. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis. Medicina (Kaunas) 2019;55:E20. [PMID: 30658502 DOI: 10.3390/medicina55010020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
13 Ma L, Liang Z, Zhou H, Qu L. Applications of RNA Indexes for Precision Oncology in Breast Cancer. Genomics Proteomics Bioinformatics 2018;16:108-19. [PMID: 29753129 DOI: 10.1016/j.gpb.2018.03.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
14 Faruque F, Noh H, Hussain A, Neuberger E, Onukwugha E. Economic Value of Pharmacogenetic Testing for Cancer Drugs with Clinically Relevant Drug-Gene Associations: A Systematic Literature Review. J Manag Care Spec Pharm 2019;25:260-71. [PMID: 30698084 DOI: 10.18553/jmcp.2019.25.2.260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Shui L, Ren H, Yang X, Li J, Chen Z, Yi C, Zhu H, Shui P. The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology. Front Oncol 2020;10:570465. [PMID: 33575207 DOI: 10.3389/fonc.2020.570465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tang G, Cho M, Wang X. OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res 2021:gkab970. [PMID: 34718715 DOI: 10.1093/nar/gkab970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hasanzad M, Sarhangi N, Aghaei Meybodi HR, Nikfar S, Khatami F, Larijani B. Precision Medicine in Non Communicable Diseases. Int J Mol Cell Med 2019;8:1-18. [PMID: 32351905 DOI: 10.22088/IJMCM.BUMS.8.2.1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Seyfoori A, Seyyed Ebrahimi SA, Samiei E, Akbari M. Multifunctional Hybrid Magnetic Microgel Synthesis for Immune-Based Isolation and Post-Isolation Culture of Tumor Cells. ACS Appl Mater Interfaces 2019;11:24945-58. [DOI: 10.1021/acsami.9b02959] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kim JJ, Park HM, Kyoung AY, Park IK, Lim SK, Park BC. Inclusion of double helix structural oligonucleotide (STexS) results in an enhance of SNP specificity in PCR. Sci Rep 2021;11:19098. [PMID: 34580382 DOI: 10.1038/s41598-021-98610-8] [Reference Citation Analysis]
20 Jiang T, Zheng L, Li X, Liu J, Song H, Xu Y, Dong C, Liu L, Wang H, Wang S, Wang R, Song J. Quiescin Sulfhydryl Oxidase 2 Overexpression Predicts Poor Prognosis and Tumor Progression in Patients With Colorectal Cancer: A Study Based on Data Mining and Clinical Verification. Front Cell Dev Biol 2021;9:678770. [PMID: 34858968 DOI: 10.3389/fcell.2021.678770] [Reference Citation Analysis]
21 Ahluwalia P, Kolhe R, Gahlay GK. The clinical relevance of gene expression based prognostic signatures in colorectal cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188513. [PMID: 33493614 DOI: 10.1016/j.bbcan.2021.188513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Shukla S, Khadirnaikar S. RNA-Sequencing Analysis Pipeline for Prognostic Marker Identification in Cancer. In: Robles-flores M, editor. Cancer Cell Signaling. New York: Springer US; 2021. pp. 119-31. [DOI: 10.1007/978-1-0716-0759-6_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Yang QY, Hu YH, Guo HL, Xia Y, Zhang Y, Fang WR, Li YM, Xu J, Chen F, Wang YR, Wang TF. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor. Front Pharmacol 2021;12:771487. [PMID: 34955843 DOI: 10.3389/fphar.2021.771487] [Reference Citation Analysis]
24 Iliopoulos A, Beis G, Apostolou P, Papasotiriou I. Complex Networks, Gene Expression and Cancer Complexity: A Brief Review of Methodology and Applications. CBIO 2020;15:629-55. [DOI: 10.2174/1574893614666191017093504] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Uozumi R, Yada S, Kawaguchi A. Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints. BMC Med Res Methodol 2019;19:159. [PMID: 31331277 DOI: 10.1186/s12874-019-0800-2] [Reference Citation Analysis]
26 Branca M, Orso S, Molinari RC, Xu H, Guerrier S, Zhang Y, Mili N. Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers? Melanoma Res 2018;28:21-9. [PMID: 29194095 DOI: 10.1097/CMR.0000000000000412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
27 Zhang ZH, Luan ZY, Han F, Chen HQ, Liu WB, Liu JY, Cao J. Diagnostic and prognostic value of the BEX family in lung adenocarcinoma. Oncol Lett 2019;18:5523-33. [PMID: 31612060 DOI: 10.3892/ol.2019.10905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Roškar L, Klančič T, Knific T, Rižner TL, Smrkolj Š. Tie-2, G-CSF, and Leptin as Promising Diagnostic Biomarkers for Endometrial Cancer: A Pilot Study. J Clin Med 2021;10:765. [PMID: 33671851 DOI: 10.3390/jcm10040765] [Reference Citation Analysis]
29 Molinski J, Tadimety A, Burklund A, Zhang JXJ. Scalable Signature-Based Molecular Diagnostics Through On-chip Biomarker Profiling Coupled with Machine Learning. Ann Biomed Eng 2020;48:2377-99. [PMID: 32816167 DOI: 10.1007/s10439-020-02593-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 He J, Chen Z, Xue Q, Sun P, Wang Y, Zhu C, Shi W. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. J Transl Med 2022;20:186. [PMID: 35468826 DOI: 10.1186/s12967-022-03393-9] [Reference Citation Analysis]
31 Ikeda Y, Sato S, Yabuno A, Shintani D, Ogasawara A, Miwa M, Zewde M, Miyamoto T, Fujiwara K, Nakamura Y, Hasegawa K. High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo. J Gynecol Oncol 2020;31:e93. [PMID: 33078598 DOI: 10.3802/jgo.2020.31.e93] [Reference Citation Analysis]
32 Otálora-Otálora BA, Florez M, López-Kleine L, Canas Arboleda A, Grajales Urrego DM, Rojas A. Joint Transcriptomic Analysis of Lung Cancer and Other Lung Diseases. Front Genet 2019;10:1260. [PMID: 31867044 DOI: 10.3389/fgene.2019.01260] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Buzdin A, Sorokin M, Garazha A, Glusker A, Aleshin A, Poddubskaya E, Sekacheva M, Kim E, Gaifullin N, Giese A, Seryakov A, Rumiantsev P, Moshkovskii S, Moiseev A. RNA sequencing for research and diagnostics in clinical oncology. Semin Cancer Biol 2020;60:311-23. [PMID: 31412295 DOI: 10.1016/j.semcancer.2019.07.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
34 Kim A, Shin JY, Seo JS. Genomic and transcriptomic analyses reveal a tandem amplification unit of 11 genes and mutations in mismatch repair genes in methotrexate-resistant HT-29 cells. Exp Mol Med 2021;53:1344-55. [PMID: 34521988 DOI: 10.1038/s12276-021-00668-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, Hricak H, Sutton EJ, Morris EA. Background, current role, and potential applications of radiogenomics.J Magn Reson Imaging. 2018;47:604-620. [PMID: 29095543 DOI: 10.1002/jmri.25870] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 14.2] [Reference Citation Analysis]
36 Bhat ZI, Naseem A, Kumar B, Ponnusamy K, Tiwari RR, Sharma GD, Rizvi MMA. Association of PARK-2 Non-synonyms Polymorphisms and Their In Silico Validation Among North Indian Colorectal Cancer Patients. J Gastrointest Cancer 2021. [PMID: 34467515 DOI: 10.1007/s12029-021-00693-z] [Reference Citation Analysis]
37 Oshi M, Katsuta E, Yan L, Ebos JML, Rashid OM, Matsuyama R, Endo I, Takabe K. A Novel 4-Gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer. Cancers (Basel) 2020;12:E1148. [PMID: 32370309 DOI: 10.3390/cancers12051148] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
38 Carrasco C, Tittarelli A, Paillaleve N, Pozo MD, Rojas-Sepúlveda D, Barría O, Fluxá P, Hott M, Martin C, Quezada C, Salazar-Onfray F. The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder-Cancer Patients. Diagnostics (Basel) 2021;11:153. [PMID: 33494186 DOI: 10.3390/diagnostics11020153] [Reference Citation Analysis]
39 Li X, Sun H, Hou Y, Jin W. Comprehensive Combined Proteomics and Genomics Analysis Identifies Prognostic Related Transcription Factors in Breast Cancer and Explores the Role of DMAP1 in Breast Cancer. J Pers Med 2021;11:1068. [PMID: 34834420 DOI: 10.3390/jpm11111068] [Reference Citation Analysis]